Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOEC study in type 2 diabetes for endothelial and nephron-on-chip modeling
NL-OMON46605Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2018
- Countries
- 1
01
Overview
Open-label trial in type 2 diabetes mellitus (T2DM), sponsored by Leiden University Medical Center. Primary endpoints: Cell metabolism, Endothelial maturation markers and 1 more. Started Oct 2018; status: active, not recruiting.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON46605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46605.